Wire Stories

Valaris Reports Second Quarter 2022 Results

Continued Strong Operational Performance – 97% Revenue Efficiency in 2Q 2022 Four Floater Reactivation Projects Completed in Advance of Multi-Year…

4 years ago

Scrut Automation Launches ‘Risk Management’ for Cloud-Based Companies

Scrut Risk Management is designed to help customers manage their risks more effectively. The tool streamlines risk assessments by automating…

4 years ago

InnoCare Announces First Subject Dosed in Clinical Trial of TYK2 JH2 Allosteric Inhibitor ICP-488 in China

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today…

4 years ago

Center Coast Brookfield MLP & Energy Infrastructure Fund Considering Strategic Options

NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Brookfield Public Securities Group (“PSG”), the investment adviser to Center Coast Brookfield…

4 years ago

V-SQUARE announces launch of V-Square MSCI Global Equity ESG Materiality and Carbon Transition Indexed Strategy for Australian Asset Owners

CHICAGO--(BUSINESS WIRE)--#Australia--Chicago based V-Square Quantitative Management LLC (V-Square), a global asset management firm with sustainability at its core, announced today…

4 years ago

Sinclair Announces Agreements with Korean Broadcasters to Further NextGen Broadcasting

HUNT VALLEY, Md.--(BUSINESS WIRE)--Sinclair Broadcast Group, Inc. (Nasdaq: SBGI), today announced that the company has entered into agreements with two…

4 years ago

CF Industries Holdings, Inc. Reports First Half 2022 Net Earnings of $2.05 Billion, Adjusted EBITDA of $3.60 Billion

Strong Operational Performance and Wide Energy Spreads Drive Record Results DEERFIELD, Ill.--(BUSINESS WIRE)--CF Industries Holdings, Inc. (NYSE: CF), a leading…

4 years ago

Navidea Biopharmaceuticals Announces Publication of Study Examining Use of Tc99m Tilmanocept for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Melanoma and Oral Cancer in Australia

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision…

4 years ago

Fabrinet to Announce Fourth Quarter and Fiscal-Year 2022 Financial Results on August 15, 2022

BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to…

4 years ago

GC Biopharma Reports Q2 2022 Results

YONGIN, South Korea--(BUSINESS WIRE)--GC Biopharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced…

4 years ago